Clinical Trial Update: Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update for HIV treatment-naive subjects evaluating raltegravir plus lopinavir/ritonavir or emtricitabine/tenofovir; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine/Tenofovir disoproxil fumarate (emtricitabine/tenofovir disoproxil fumarate)
• Lopinavir/ritonavir (lopinavir/ritonavir)
• Raltegravir (raltegravir)

Snippet

Sponsor: Margaret A. Fischl, M.D. | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2015-07-13